Factors Associated With Neurocognitive Impairment Following Chemoradiotherapy in Patients With High-Grade Glioma: Results of a Prospective Trial.

Sharma, Prashasti; Medhi, Partha Pratim; Kalita, Apurba Kumar; Bhattacharyya, Mouchumee; Nath, Jyotiman; Sarma, Gautam; Yanthan, Yanpothung

Sharma, Prashasti; Medhi, Partha Pratim; Kalita, Apurba Kumar; Bhattacharyya, Mouchumee; Nath, Jyotiman; Sarma, Gautam; Yanthan, Yanpothung.

Afiliação

Sharma P; Department of Radiation Oncology, Dr. B. Borooah Cancer Institute, Guwahati, Assam, India. prashasti1993@yahoo.com.
Medhi PP; Department of Radiation Oncology, All India Institute of Medical Sciences, Guwahati, Assam, India.
Kalita AK; Department of Radiation Oncology, Dr. B. Borooah Cancer Institute, Guwahati, Assam, India.
Bhattacharyya M; Department of Radiation Oncology, Dr. B. Borooah Cancer Institute, Guwahati, Assam, India.
Nath J; Department of Radiation Oncology, Dr. B. Borooah Cancer Institute, Guwahati, Assam, India.
Sarma G; Department of Radiation Oncology, All India Institute of Medical Sciences, Guwahati, Assam, India.
Yanthan Y; Department of Radiation Oncology, Dr. B. Borooah Cancer Institute, Guwahati, Assam, India.

Brain Tumor Res Treat ; 11(3): 183-190, 2023 Jul.

Article em En | MEDLINE | ID: mdl-37550818

Palavras-chave

Cognition; Glioma; Hippocampus; Isocitrate dehydrogenase; Mental status and dementia tests; Radiotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google